Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Warfarin: pharmacological profile and drug interactions with antidepressants.

Teles JS, Fukuda EY, Feder D.

Einstein (Sao Paulo). 2012 Jan-Mar;10(1):110-5. Review.

2.

Antidepressant interactions with warfarin.

Duncan D, Sayal K, McConnell H, Taylor D.

Int Clin Psychopharmacol. 1998 Mar;13(2):87-94. Review.

PMID:
9669190
3.

Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.

Jacobs LG.

Cardiol Clin. 2008 May;26(2):157-67, v. doi: 10.1016/j.ccl.2007.12.010. Review.

PMID:
18406992
4.

Warfarin--indications, risks and drug interactions.

Tadros R, Shakib S.

Aust Fam Physician. 2010 Jul;39(7):476-9. Review.

5.

Drug-drug interactions between warfarin and psychotropics: updated review of the literature.

Nadkarni A, Oldham MA, Howard M, Berenbaum I.

Pharmacotherapy. 2012 Oct;32(10):932-42. doi: 10.1002/j.1875-9114.2012.01119. Review.

PMID:
23033232
6.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
7.

Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification.

Cabral KP, Ansell J, Hylek EM.

J Thromb Haemost. 2011 Mar;9(3):441-9. doi: 10.1111/j.1538-7836.2010.04179.x. Review.

8.

Dronedarone and vitamin K antagonists: a review of drug-drug interactions.

Shirolkar SC, Fiuzat M, Becker RC.

Am Heart J. 2010 Oct;160(4):577-82. doi: 10.1016/j.ahj.2010.07.008. Review.

PMID:
20934550
9.

Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.

Nutescu E, Chuatrisorn I, Hellenbart E.

J Thromb Thrombolysis. 2011 Apr;31(3):326-43. doi: 10.1007/s11239-011-0561-1. Review.

PMID:
21359645
10.

[Rivaroxaban: mode of action].

Drouet L.

Ann Fr Anesth Reanim. 2008 Dec;27 Suppl 3:S9-15. doi: 10.1016/S0750-7658(08)75141-4. Review. French.

PMID:
19185786
11.

Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model.

Miki A, Ohtani H, Sawada Y.

J Clin Pharm Ther. 2011 Dec;36(6):642-50. doi: 10.1111/j.1365-2710.2010.01229.x. Epub 2010 Dec 8. Review.

PMID:
21143257
12.

Warfarin therapy: evolving strategies in anticoagulation.

Horton JD, Bushwick BM.

Am Fam Physician. 1999 Feb 1;59(3):635-46. Review. Erratum in: Am Fam Physician 2002 Jan 15;65(2):172. Am Fam Physician. 2006 Mar 15;73(6):974. Am Fam Physician 1999 Oct 1;60(5):1333.

13.

Warfarin resistance and enteral tube feeding: a vitamin K-independent interaction.

Dickerson RN.

Nutrition. 2008 Oct;24(10):1048-52. doi: 10.1016/j.nut.2008.05.015. Epub 2008 Jul 7. Review. No abstract available.

PMID:
18602249
14.

Pharmacogenetics of oral anticoagulants.

Daly AK, King BP.

Pharmacogenetics. 2003 May;13(5):247-52. Review.

PMID:
12724615
15.

Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system.

Preskorn SH, Nichols AI, Paul J, Patroneva AL, Helzner EC, Guico-Pabia CJ.

J Psychiatr Pract. 2008 Nov;14(6):368-78. doi: 10.1097/01.pra.0000341891.43501.6b. Review.

PMID:
19057238
16.

Warfarin and its interactions with foods, herbs and other dietary supplements.

Nutescu EA, Shapiro NL, Ibrahim S, West P.

Expert Opin Drug Saf. 2006 May;5(3):433-51. Review.

PMID:
16610971
17.

Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies.

Fusaro M, Crepaldi G, Maggi S, D'Angelo A, Calo L, Miozzo D, Fornasieri A, Gallieni M.

Curr Vasc Pharmacol. 2011 Nov;9(6):763-9. Review.

PMID:
21623708
18.

Old versus new oral anticoagulants: focus on pharmacology.

Fareed J, Thethi I, Hoppensteadt D.

Annu Rev Pharmacol Toxicol. 2012;52:79-99. doi: 10.1146/annurev-pharmtox-010611-134633. Epub 2011 Aug 5. Review.

PMID:
21819239
19.

Novel anticoagulants and the future of anticoagulation.

Garcia D.

Thromb Res. 2009;123 Suppl 4:S50-5. doi: 10.1016/S0049-3848(09)70144-6. Review.

PMID:
19303505
20.

Current recommendations for warfarin therapy. Use and monitoring.

Triplett DA.

Med Clin North Am. 1998 May;82(3):601-11. Review.

PMID:
9646782

Supplemental Content

Support Center